# Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial

> **NCT01528826** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 35 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** vinorelbine plus oxaliplatin

## Key facts

- **NCT ID:** NCT01528826
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2012-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01528826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01528826, "Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01528826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*